2016-03-05T00:00:00.000-05:00
EQIS Capital Management,0.318204
Exchange Commission,0.426446
Foothills Asset Management,0.280579
strong buy rating,0.365284
business’s stock,-0.22973
Company LLC,0.327009
stock,0.117394
consensus price target,0.488732
hold rating,0.3564
recent filing,0.426447
Eagle Asset Management,0.366628
InvestorPlace Broker Center,0.555736
chief operating officer,0.225388
Renaissance Investment Group,0.339285
Asset Management Ltd.,0.280579
research report,0.395402
biopharmaceutical company,0.395623
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
target price,0.395402
ex-dividend date,-0.33715
Gilead Sciences Inc.,0.555178
Stillwater Investment Management,0.408881
COO John F.,-0.22973
average price,0.255265
shares,0.111219
concise daily summary,0.447788
Gilead Sciences,0.207861
Park National,0.298057
stock broker,0.245696
consensus rating,0.52876
chronic hepatitis,-0.646567
quarter,-0.0483643
